Aneurysmal SubArachnoid Hemorrhage-Red Blood Cell Transfusion and Outcome (SAHaRA): A pilot randomised controlled trial protocol

BMJ Open

Volumn 6, Issue 12, 2016, Pages

  English, Shane W ^a,b   Fergusson, D ^a,b   Chasse M ^c,d   Turgeon, A F ^e   Lauzier, F ^e   Griesdale, D ^f   Algird, A ^g   Kramer, A ^h,i   Tinmouth, A ^a,b   Lum, C ^b   Sinclair, J ^b   Marshall, S ^a,b   Dowlatshahi, D ^a,b   Boutin, A ^e   Pagliarello, G ^b   McIntyre, L A ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e UNIVERSITÉ LAVAL   (Canada)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g MCMASTER UNIVERSITY   (Canada)

^h UNIVERSITY OF CALGARY   (Canada)

ⁱ UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADULT; ANEMIA; ARTICLE; CONTROLLED STUDY; DISABILITY SEVERITY; ERYTHROCYTE TRANSFUSION; FEASIBILITY STUDY; FEMALE; FOLLOW UP; FUNCTIONAL INDEPENDENCE MEASURE; HEMOGLOBIN BLOOD LEVEL; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; OUTCOME ASSESSMENT; PILOT STUDY; PROTOCOL COMPLIANCE; QUALITY OF LIFE ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; SUBARACHNOID HEMORRHAGE; TERTIARY CARE CENTER; YOUNG ADULT; CLINICAL PROTOCOL; CLINICAL TRIAL; DISABILITY; ENDOVASCULAR SURGERY; EPIDEMIOLOGY; INTENSIVE CARE; MORTALITY; NORTH AMERICA; PATHOPHYSIOLOGY; PROCEDURES; QUALITY OF LIFE; RISK FACTOR; TREATMENT OUTCOME;

ANEMIA; CLINICAL PROTOCOLS; CRITICAL CARE; DISABILITY EVALUATION; ENDOVASCULAR PROCEDURES; ERYTHROCYTE TRANSFUSION; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; NORTH AMERICA; OUTCOME ASSESSMENT (HEALTH CARE); PILOT PROJECTS; QUALITY OF LIFE; RISK FACTORS; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

EID: 85004074711     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2016-012623     Document Type: Article

References (58)

1. Johnston SC, Selvin S, Gress DR. The burden, trends, anddemographics of mortality from subarachnoid hemorrhage. Neurology 1998;50:1413-18.
2. Reed SD, Blough DK, Meyer K, et al. Inpatient costs, length of stay, and mortality for cerebrovascular events in community hospitals. Neurology 2001;57:305-14.
3. Nieuwkamp DJ, Setz LE, Algra A, et al. Changes in case fatality ofaneurysmal subarachnoid haemorrhage over time, according toage, sex, region: a meta-analysis. Lancet Neurol2009;8:635-42.
4. Le Roux PD. Anemia, transfusion after subarachnoidhemorrhage. Neurocrit Care 2011;15:342-53.
5. Springer MV, Schmidt JM, Wartenberg KE, et al. Predictors of globalcognitive impairment 1 year after subarachnoid hemorrhage. Neurosurgery 2009;65:1043-50; discussion 1050-1.
6. Sampson TR, Dhar R, Diringer MN. Factors associated with thedevelopment of anemia after subarachnoid hemorrhage. NeurocritCare 2010;12:4-9.
7. Naidech AM, Drescher J, Ault ML, et al. Higher hemoglobin isassociated with less cerebral infarction, poor outcome, deathafter subarachnoid hemorrhage. Neurosurgery 2006;59:775-9.
8. Wartenberg KE, Mayer SA. Medical complications aftersubarachnoid hemorrhage: new strategies for prevention andmanagement. Curr Opin Crit Care 2006;12:78-84.
9. Naidech AM, Jovanovic B, Wartenberg KE, et al. Higher hemoglobinis associated with improved outcome after subarachnoidhemorrhage. Crit Care Med 2007;35:2383-9.
10. Kramer AH, Gurka MJ, Nathan B, et al. Complications associatedwith anemia, blood transfusion in patients with aneurysmalsubarachnoid hemorrhage. Crit Care Med 2008;36:2070-5.
11. Kramer AH, Zygun DA. Anemia, red blood cell transfusion inneurocritical care. Crit Care 2009;13:R89.
12. Amin M, Fergusson D, Wilson K, et al. The societal unit cost ofallogenic red blood cells, red blood cell transfusion in Canada. Transfusion 2004;44:1479-86.
13. Smith MJ, Le Roux PD, Elliott JP, et al. Blood transfusion andincreased risk for vasospasm, poor outcome after subarachnoidhemorrhage. J Neurosurg 2004;101:1-7.
14. Broessner G, Lackner P, Hoefer C, et al. Influence of red blood celltransfusion on mortality, long-term functional outcome in 292patients with spontaneous subarachnoid hemorrhage. Crit Care Med2009;37:1886-92.
15. Levine J, Kofke A, Cen L, et al. Red blood cell transfusion isassociated with infection, extracerebral complications aftersubarachnoid hemorrhage. Neurosurgery 2010;66:312-18;discussion 318.
16. Taylor C, Gough K, Gross MS J. Transfusion threshold for acuteaneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol2012;24:254-5.
17. Mauricio E, Robinson M, Dajac J, et al. Anemia, transfusionthresholds, incidence of vasospasm, infarction amongpatients with aneurysmal subarachnoid hemorrhage. Crit Care Med2010;38:A86.
18. Naidech AM, Shaibani A, Garg RK, et al. Prospective, randomizedtrial of higher goal hemoglobin after subarachnoid hemorrhage. Neurocrit Care 2010;13:313-20.
19. Connolly ES, Rabinstein AA, Carhuapoma JR, et al. Guidelines forthe management of aneurysmal subarachnoid hemorrhage: aguideline for healthcare professionals from the American HeartAssociation/American Stroke Association. Stroke 2012;43:1711-37.
20. Diringer MN, Bleck TP, Claude Hemphill J, et al. Critical caremanagement of patients following aneurysmal subarachnoidhemorrhage: recommendations from the Neurocritical Care Society'sMultidisciplinary Consensus Conference. Neurocrit Care2011;15:211-40.
21. Lacroix J, Hébert PC, Hutchison JS, et al. Transfusion strategies forpatients in pediatric intensive care units. N Engl J Med2007;356:1609-19.
22. Hébert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements incritical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med1999;340:409-17.
23. Kramer AH, Diringer MN, Suarez JI, et al. Red blood cell transfusionin patients with subarachnoid hemorrhage: a multidisciplinary NorthAmerican survey. Crit Care 2011;15:R30.
24. Kramer AH, Zygun DA, Bleck TP, et al. Relationship betweenhemoglobin concentrations, outcomes across subgroups ofpatients with aneurysmal subarachnoid hemorrhage. Neurocrit Care2009;10:157-65.
25. English SW, Chasse M, Turgeon A, et al. Aneurysmal subarachnoidhemorrhage, anemia: a Canadian multi-centre retrospectivecohort study. Crit Care 2016;20:P337.
26. Dhar R, Scalfani MT, Zazulia AR, et al. Comparison of inducedhypertension, fluid bolus, blood transfusion to augment cerebraloxygen delivery after subarachnoid hemorrhage. J Neurosurg2012;116:648-56.
27. Smith MJ, Stiefel MF, Magge S, et al. Packed red blood celltransfusion increases local cerebral oxygenation. Crit Care Med2005;33:1104-8.
28. Kurtz P, Helbok R, Claassen J, et al. Effect of packed red blood celltransfusion on cerebral oxygenation, metabolism aftersubarachnoid hemorrhage. Crit Care 2010;14:P341.
29. Dhar R, Zazulia AR, Videen TO, et al. Red blood cell transfusionincreases cerebral oxygen delivery in anemic patients withsubarachnoid hemorrhage. Stroke 2009;40:3039-44.
30. Kurtz P, Schmidt JM, Claassen J, et al. Anemia is associated withmetabolic distress, brain tissue hypoxia after subarachnoidhemorrhage. Neurocrit Care 2010;13:10-16.
31. English SW, Chassé M, Turgeon A, et al. Red blood cell transfusionin aneurysmal subarachnoid hemorrhage-the Sahara cohort study. Crit Care 2016;20:P336.
32. Jauch EC, Saver JL, Adams HP, et al. Guidelines for the earlymanagement of patients with acute ischemic stroke: a guidelinefor healthcare professionals from the American HeartAssociation/American Stroke Association. Stroke 2013;44:870-947.
33. Lindsay M, Gubitz G, Bayley M, et al. Canadian Best PracticeRecommendations for Stroke Care (Update 2010). On behalf of theCanadian Stroke Strategy Best Practices, Standards WritingGroup. 2010; Ottawa, Ontario Canada: Canadian Stroke Network.
34. Salter K, Campbell N, Richardson M, et al. Outcome measures instroke rehabilitation. In: Evidence based research in strokerehabilitation. London ON: EBRSR; October 2013:1-144. Availableat www. EBRSR. com
35. Sullivan JE, Crowner BE, Kluding PM, et al. Outcome measures forindividuals with stroke: process, recommendations from theAmerican Physical Therapy Association neurology section taskforce. Phys Ther 2013;93:1383-96.
36. Hop JW, Rinkel GJ, Algra A, et al. Case-fatality rates, functionaloutcome after subarachnoid hemorrhage: a systematic review. Stroke 1997;28:660-4.
37. Nieuwkamp DJ, De Gans K, Rinkel GJ, et al. Treatment andoutcome of severe intraventricular extension in patients withsubarachnoid or intracerebral hemorrhage: a systematic review ofthe literature. J Neurol 2000;247:117-21.
38. Kirkpatrick PJ, Turner CL, Smith C, et al. Simvastatin in aneurysmalsubarachnoid haemorrhage (STASH): a multicentre randomisedphase 3 trial. Lancet Neurol 2014;13:666-75.
39. Dorhout Mees SM, Algra A, Vandertop WP, et al. Magnesium foraneurysmal subarachnoid haemorrhage (MASH-2): a randomisedplacebo-controlled trial. Lancet 2012;380:44-9.
40. Banks JL, Marotta CA. Outcomes validity, reliability ofthe modified Rankin scale: implications for stroke clinicaltrials: a literature review, synthesis. Stroke 2007;38:1091-6.
41. Wilson JTL, Hareendran A, Hendry A, et al. Reliability of themodified Rankin Scale across multiple raters: benefits of a structuredinterview. Stroke 2005;36:777-81.
42. Wilson JT, Hareendran A, Grant M, et al. Improving the assessmentof outcomes in stroke: use of a structured interview to assign gradeson the modified Rankin scale. Stroke 2002;33:2243-6.
43. Savio K, Pietra GL, Oddone E, et al. Reliability of the modifiedRankin Scale applied by telephone. Neurol Int 2013;5:e2.
44. O'Dell MW, Watanabe TK, De Roos ST, et al. Functional outcomeafter inpatient rehabilitation in persons with subarachnoidhemorrhage. Arch Phys Med Rehabil 2002;83:678-82.
45. Linacre JM, Heinemann AW, Wright BD, et al. The structure andstability of the functional independence measure. Arch Phys MedRehabil 1994;75:127-32.
46. Dromerick AW, Edwards DF, Diringer MN. Sensitivity to changes indisability after stroke: a comparison of four scales useful in clinicaltrials. J Rehabil Res Dev 2003;40:1-8.
47. Beninato M, Gill-Body KM, Salles S, et al. Determination of theminimal clinically important difference in the FIM instrument inpatients with stroke. Arch Phys Med Rehabil 2006;87:32-9.
48. Wartenberg KE, Schmidt JM, Claassen J, et al. Impact of medicalcomplications on outcome after subarachnoid hemorrhage. Crit CareMed 2006;34:617-23; quiz 624.
49. Rivero Rodríguez D, Scherle Matamoros C, Fernández Cué L, et al. Factors associated with poor outcome for aneurysmalsubarachnoid hemorrhage in a series of 334 patients. NeurologiaEPub Feb 2015.
50. Molyneux AJ, Kerr RS, Yu LM, et al. International subarachnoidaneurysm trial (ISAT) of neurosurgical clipping versus endovascularcoiling in 2143 patients with ruptured intracranial aneurysms: arandomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, aneurysm occlusion. Lancet2005;366:809-17.
51. Geocadin RG, Bleck TP, Koroshetz WJ, et al. Research priorities inneurocritical care. Neurocrit Care 2012;16:35-41.
52. Thabane L, Ma J, Chu R, et al. A tutorial on pilot studies: the what, why, how. BMC Med Res Methodol 2010;10:1.
53. Carson JL, Terrin ML, Noveck H, et al. Liberal or restrictivetransfusion in high-risk patients after hip surgery. N Engl J Med2011;365:2453-62.
54. Carson JL, Brooks MM, Abbott JD, et al. Liberal versus restrictivetransfusion thresholds for patients with symptomatic coronary arterydisease. Am Heart J 2013;165:964-71.e1.
55. Hajjar LA, Vincent JL, Galas FR, et al. Transfusion requirementsafter cardiac surgery: the TRACS randomized controlled trial. JAMA2010;304:1559-67.
56. Campbell BC, Mitchell PJ, Kleinig TJ, et al. Endovascular therapyfor ischemic stroke with perfusion-imaging selection. N Engl J Med2015;372:1009-18.
57. Goyal M, Demchuk AM, Menon BK, et al. Randomized assessmentof rapid endovascular treatment of ischemic stroke. N Engl J Med2015;372:1019-30.
58. Butcher KS, Jeerakathil T, Hill M, et al. The intracerebralhemorrhage acutely decreasing arterial pressure trial. Stroke2013;44:620-6.